Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2008
12/31/2008EP2007702A2 Conjugated lipid derivatives
12/31/2008EP2007602A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
12/31/2008EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof
12/31/2008EP2007368A2 Compositions and methods for enhancing the antioxidant status of animals
12/31/2008EP2007227A2 Lycopene for the treatment of metabolic dysfunction
12/31/2008EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
12/31/2008EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
12/31/2008EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1402788B1 Body temperature-raising agent of amino acids for eating or drinking and for medical use
12/31/2008EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/31/2008EP1218001B1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/31/2008CN101336253A Chitin derivatives for hyperlipidemia
12/31/2008CN101336235A 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
12/31/2008CN101333256A Human antibodies that bind human il-12 and methods for producing
12/31/2008CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof
12/31/2008CN101332303A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
12/31/2008CN101332294A Use of human-source adiponcetin globular segment for medicine for treating diabetes and ischemic heart disease
12/31/2008CN101332293A High-calcium soft chewable tablets and production method
12/31/2008CN101332277A Preparation method of emergency liquor for raising the whole blood
12/31/2008CN101332257A Medicine composition for preventing the birth defect and improving the memory
12/31/2008CN101332229A Prunella plant extract, preparation method and use thereof
12/31/2008CN101332228A Traditional Chinese medicine composition for treating disease with common pathogenic basis of í«insulin resistanceí», such as type ó diabetic
12/31/2008CN101332220A Preparation method of extracting and separating potato vine polysaccharide from natural plant sweet potato vine
12/31/2008CN101332207A Artemisia glue polysaccharide for preparing medicine for reducing weight and blood fat
12/31/2008CN101332195A Compound branched chain amino acid injection
12/31/2008CN101332190A Sugar-free type citrulline effervescence tablet and preparation method thereof
12/31/2008CN101332188A Method for preparing powder injection using superfine communication technique and prepared products
12/31/2008CN101332184A Sugar-free type citrulline mouth spray and preparation method thereof
12/31/2008CN101332169A Preparation method of thymopentin formulation for nasal administration
12/31/2008CN101331964A Rosa multiflora beverage and preparation method thereof
12/31/2008CN101331946A 一种葛根饮料 One kind of beverage Pueraria
12/31/2008CN101331924A Method for producing inulin syrupy using waste fluid of producing inulin
12/31/2008CN101331923A Water melon meal fiber powder and preparation method and use thereof
12/31/2008CN101331906A Drink containing Congrong and coffee
12/31/2008CN100447160C Modified acacia and use thereof
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100447139C Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
12/31/2008CN100446776C Superoxide anion decomposing agent
12/31/2008CN100446772C Treatment of diabetes
12/31/2008CN100446764C Vitamic C controlled release pill and its preparation method and use
12/31/2008CN100446762C (-)-epigallocatechin gallate solid dispersion and its prepn and application
12/31/2008CN100446757C Pharmaceutical compositions comprising atorvastatin manufactured without granulation
12/31/2008CN100446681C Fat-weight-reducing food
12/31/2008CA2691425A1 Compositions for the treatment of hyperphenylalaninemia
12/31/2008CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008CA2691010A1 Substituted fused pyrimidines as antagonists of gpr105 activity
12/30/2008US7470719 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/30/2008US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
12/30/2008US7470687 Aryl oximes
12/30/2008US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis
12/30/2008US7470681 Pyrimidine compounds
12/30/2008US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
12/30/2008US7470663 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/30/2008CA2501601C Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof
12/30/2008CA2391293C .beta.2-adrenergic receptor agonists
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2281251C Sterol esters in tableted solid dosage forms
12/30/2008CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds
12/30/2008CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents
12/25/2008US20080319222 Crystal forms of N- (trans-4-isopropylctyclohexylcarbonyl) -D-phenylalanine
12/25/2008US20080319078 Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
12/25/2008US20080319077 Remedy for Diabetes
12/25/2008US20080319074 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
12/25/2008US20080319052 Lipopexia Inhibitor and Food or Beverage
12/25/2008US20080319049 Compounds For the Treatment of Metabolic Disorders
12/25/2008US20080319047 Novel Glucitol Derivative, Prodrug Thereof And Salt Thereof, And Therapeutic Agent Containing The Same For Diabetes
12/25/2008US20080319046 Substituted sulfonamide-indoles
12/25/2008US20080319044 Compounds and Methods of Use Thereof
12/25/2008US20080319040 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents
12/25/2008US20080319036 administering to overweight subject a pharmaceutical composition comprising a sustained release formulation of zonisamide or a pharmaceutically acceptable salt thereof, either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake
12/25/2008US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents
12/25/2008US20080319031 Novel Tyrosine Derivatives
12/25/2008US20080319028 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators
12/25/2008US20080319024 Rosiglitazone Phosphate and Polymorphic Forms
12/25/2008US20080319019 Therapeutic Agents
12/25/2008US20080319014 Nitroxides for Use in Treating or Preventing Diabetes
12/25/2008US20080319010 Use of Chloroquine to Treat Metabolic Syndrome
12/25/2008US20080319002 Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists
12/25/2008US20080318991 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/25/2008US20080318990 Spiroindolines as modulators of chemokine receptors
12/25/2008US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS
12/25/2008US20080318968 Chemical Compounds
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318948 activators of glucokinase activity such as (R)-3-Cyclopentyl-N-isoquinolin-1-yl-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide, used for the prevention and the treatment of diabetes, non-insulin dependent diabetes and obesity
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
12/25/2008US20080318930 Sulfonyl Compound as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
12/25/2008US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1298